Münchener Rück AG
Explore by topic
5-year stock timeline
Münchener Rück (MUV2.XETRA) — Latest price: 495.9 (2026-07-07)
2021 — recovery, strategy set
Consolidated profit reached €2,932m with an operating result of €3,517m and RoE around 12.6%. The Board proposed a higher dividend of €11 per share, later approved at the AGM. [1, 8]
The Group launched Ambition 2025, articulating three pillars (Scale, Shape, Succeed) with explicit targets: RoE of 12–14% by 2025, EPS and DPS growth of at least 5% annually, a solvency corridor of 175–220%, and commitments to climate and decarbonisation. This framed investor expectations for multi-year execution. [45]
Price action formed a broad, constructive base through the year, trading between approximately €195 and €260 with a January low near €195.5 and December close around €239.6, with no decisive breakout yet. [15]
2022 — Ukraine shock, balance-sheet hits but guidance held
The Russia-Ukraine conflict prompted Munich Re to suspend new business in Russia and Belarus and support sanctions. The company took gross write-downs of approximately €700m on Russian and Ukrainian bonds (net ~€370m) and recorded war-related claims and charges exceeding $100m in some specialty lines during Q1. Despite this, Q1profit reached €608m and management maintained FY guidance of approximately €3.3bn. [18, 24, 19, 21, 20]
The company authorised a material buyback programme of up to approximately €1bn, and the AGM approved the raised dividend for 2021, materially shifting the capital-allocation narrative. [47, 8, 1]
The Supervisory Board announced Board-level changes, with Torsten Jeworrek stepping down and Clarisse Kopff and Mari-Lizette Malherbe appointed in December 2022 and January 2023, signalling internal reshaping ahead of the mid-cycle. [39]
Q2 included drought and natural catastrophe losses, including a cited drought loss of approximately €130m, adding near-term volatility. [6]
Price volatility marked the year: early 2022 saw peaks around €257–€280, a July low near €212, and recovery to roughly €240 by year-end, with moves aligned to war write-downs and macro uncertainty. [15, 12]
2023 — on-track execution; re-rating begins
Management reported strong operational performance and guided to higher consolidated profit of approximately €4.0bn for 2023, stating the Group was "on course" to meet Ambition 2025 targets. [51, 2]
Investors began to re-rate Munich Re from a purely defensive reinsurer to an "execution-led" earnings and capital-return story. Hardening reinsurance prices and improving investment returns amplified the case, with Ambition 2025 credibility underpinning the shift. [45, 46, 51]
The price cleared the €300 level in January 2023 around €332 and produced a strong calendar return for the year as the market rewarded both underwriting and investment improvements. [15, 10]
2024 — momentum; compounding returns
Continued reinsurance rate hardening and higher yields on the investment book meaningfully boosted RoE and EPS growth as Ambition 2025 entered its final phase. Market commentary highlighted accelerating EPS and DPS progress. [55, 49]
Consensus evolved toward viewing Munich Re as a "defensive compounder with cyclic upside" and a capital-return compounder through dividends and buybacks, rather than a mere cyclical play. [49, 50]
A broad rally continued through 2024, delivering a calendar return of approximately +28% and setting the base for the 2025 peak. [10]
2025 — Ambition 2025 delivered; valuation peak; leadership exit announced
Munich Re reported it had met or exceeded its Ambition 2025 financial and non-financial targets. RoE rose markedly to approximately 18.3% by year-end, EPS and DPS grew well above the ≥5% target, and total shareholder return over the Ambition period reached approximately 171% to 30 November 2025. [49, 50]
CEO Dr. Joachim Wenning announced his retirement at year-end 2025, with CFO Dr. Christoph Jurecka named as successor to assume the Chair on 1 January 2026 — a clean, internal succession aimed at continuity. [32, 31, 33]
A strong bull run culminated in record highs, with the highest reported end-of-day close of €709.7 on 2025-08-07. The calendar year delivered a return of approximately +34%, with peak valuation reflecting delivered execution plus buyback and dividend momentum. [10, 16]
2026 (to 2026-07-07) — new chair, fundamentals intact, post-peak correction
Dr. Christoph Jurecka became Chair of the Board of Management on 1 January 2026. The company continued to report strong results and in February 2026 said it had again surpassed profit guidance, marking the fifth consecutive year of outperformance. [42, 52]
After the 2025 peak, the stock experienced a material pullback into 2026, down approximately 19.4% year-to-date in available market summaries, reflecting profit-taking and market rotation despite continued strong fundamentals. The latest price stands at 495.9. [10]
A clear large drawdown unfolded from the 2025 high of approximately €710 into mid-2026 at approximately €496 — an aggressive de-rating and profit-taking phase following multi-year outperformance. The five-year chart phases read as: 2021 base and range, 2022 volatility and mid-year dip from Ukraine, 2023 through mid-2025 strong uptrend and breakout, August 2025 peak, and 2026 correction to current levels. [15, 10]
Key causal summary (what most moved the stock, 2021–2026)
Strategy and execution through Ambition 2025, combined with explicit capital-return targets of dividend growth and buybacks, drove a multi-year re-rating as targets were demonstrably met. [45, 49, 47]
Macro shocks, natural catastrophe events, and the Ukraine war in 2022 produced sharp, short-term volatility and forced reserve and investment adjustments. Market reaction in 2022 was driven by clarity on exposures and reserve prudence. [18, 24, 21, 6]
Rising reinsurance pricing and higher interest rates from 2023 through 2025 materially improved underlying earnings power, underpinning the 2023–2025 rally. [51, 55]
Management continuity through an internal CEO succession and completion of Ambition 2025 crystallised the "execution and compounder" narrative. The subsequent 2026 pullback appears driven more by valuation adjustment and broader market rotation than by deterioration in company fundamentals. [32, 49, 52, 10]
Key risks and downside factors
Münchener Rück (Munich Re, MUV2) operates as a leading global reinsurer in a densely populated competitive field. Direct rivals include Swiss Re (SREN, CH0126881561), Hannover Re (HNR1, DE0008402215) and SCOR (SCOR, FR0010411983), while diversified conglomerates like Berkshire Hathaway and Allianz maintain overlapping positions in reinsurance and primary insurance. The broader landscape encompasses traditional reinsurance operators, Lloyd's market participants, and an expanding base of alternative capital providers through instruments like insurance-linked securities and catastrophe bonds. The company faces structural pressures across several fronts. Exposure to large catastrophic events remains substantial, while performance tracks closely with investment returns and broader market conditions. Regulatory frameworks and solvency requirements impose ongoing constraints, and competitive intensity—sharpened by alternative capital sources willing to underwrite risks at tighter margins—continues to compress profitability across the sector.
- Natural catastrophes and climate risk represent a material underwriting challenge. Large-scale events—storms, floods, wildfires—can generate severe losses that force substantial reserve increases, sometimes catching the market off guard in their timing or severity.
- Rising yields, equity volatility, and credit losses pose interconnected risks: they compress investment income, force mark-to-market losses into view, and erode capital ratios.
- Regulatory and rating risk: shifts in Solvency II frameworks or broader regulatory regimes, along with credit or rating downgrades, can meaningfully elevate capital costs and compress underwriting capacity.
- Competitive and alternative-capital pressure continues to narrow the landscape. Soft market cycles, intense peer pricing, and the expanding capacity in ILS and cat-bond markets all work to compress both premiums and margins.
Competitive landscape
Munich Re (Münchener Rück; MUV2.XETRA) stands as a global reinsurance leader with meaningful primary-insurance operations through ERGO and a substantial asset-management business. It competes directly against other large global reinsurers and diversified insurance groups offering property & casualty, life & health, and specialty reinsurance capacity. The company's risk profile centers on catastrophe accumulation, investment and market volatility, competitive encroachment from alternative capital and ILS providers, and the shifting landscape of regulatory and ESG requirements.
| Company | Ticker |
|---|---|
| Swiss Re Ltd | SREN.SIX |
| Reinsurance Group of America, Inc. | RGA.NYSE |
| AXIS Capital Holdings Ltd | AXS.NYSE |
| Everest Re Group Ltd | EG.NYSE |
Private competitors
- Lloyd's of London
- Nephila Capital
- BMS Group
Get More Stock Analyses Like This
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialPerformance Figures of Münchener Rück AG
Relative Performance vs Benchmarks
| Period | Münchener Rück AG | vs DAX | vs S&P 500 (SPY) |
|---|---|---|---|
| 1M | +13.17% | +11.46% | +11.76% |
| 3M | -4.10% | -9.27% | -14.36% |
| 6M | +1.04% | +1.92% | -7.26% |
| 1Y | -6.49% | -9.92% | -28.36% |
| 3Y | +74.31% | +13.84% | -2.67% |
| 5Y | +168.63% | +109.03% | +84.94% |
Get More Stock Analyses Like This
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialHistorical valuation trends
How the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.
| Period | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|
| Current | 9.7 | 1.0 | 1.9 | 51.2 |
| 1Y ago | 14.5 | 1.2 | 2.4 | 23.5 |
| 3Y ago | 8.8 | 0.7 | 1.6 | -5.9 |
| 5Y ago | 15.4 | 0.5 | 1.1 | 4.5 |
Frequently Asked Questions
Where is the Münchener Rück AG stock traded?
What does Münchener Rück AG do?
What are the key metrics for MUV2.XETRA?
How has Münchener Rück AG's stock price performed?
How is MUV2.XETRA valued?
Does MUV2.XETRA pay dividends?
What are the key risks when investing in MUV2.XETRA?
- Natural catastrophes and climate risk represent a material underwriting challenge. Large-scale events—storms, floods, wildfires—can generate severe losses that force substantial reserve increases, sometimes catching the market off guard in their timing or severity.
- Rising yields, equity volatility, and credit losses pose interconnected risks: they compress investment income, force mark-to-market losses into view, and erode capital ratios.
- Regulatory and rating risk: shifts in Solvency II frameworks or broader regulatory regimes, along with credit or rating downgrades, can meaningfully elevate capital costs and compress underwriting capacity.
- Competitive and alternative-capital pressure continues to narrow the landscape. Soft market cycles, intense peer pricing, and the expanding capacity in ILS and cat-bond markets all work to compress both premiums and margins.
Who are the main competitors of Münchener Rück AG?
- Swiss Re Ltd (SREN.SIX)
- Reinsurance Group of America, Inc. (RGA.NYSE)
- AXIS Capital Holdings Ltd (AXS.NYSE)
- Everest Re Group Ltd (EG.NYSE)
When does Münchener Rück AG report earnings?
Key Metrics
Valuation Metrics
Profitability Metrics
Growth Metrics
Dividend history
Long-term record of paid dividends (amount per share and dividend yield at the time of payment).
| Year | Dividend | Yield at payment | Avg. yield |
|---|---|---|---|
| 2026 | 24.00 EUR | 4.56% | 4.24% |
| 2025 | 20.00 EUR | 3.32% | |
| 2024 | 15.00 EUR | 3.54% | |
| 2023 | 11.60 EUR | 3.43% | |
| 2022 | 11.00 EUR | 4.56% | |
| 2021 | 9.80 EUR | 3.81% | |
| 2020 | 9.80 EUR | 4.44% | |
| 2019 | 9.25 EUR | 4.15% | |
| 2018 | 8.60 EUR | 4.35% | |
| 2017 | 8.60 EUR | 4.54% | |
| 2016 | 8.25 EUR | 4.74% | |
| 2015 | 7.75 EUR | 4.06% | |
| 2014 | 7.25 EUR | 4.36% | |
| 2013 | 7.00 EUR | 4.41% | |
| 2012 | 6.25 EUR | 5.34% |
Earnings history & estimates
Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.
Historical earnings performance
Upcoming earnings report
Analyst estimates for upcoming periods
Key financial figures
Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 69.30B | 69.11B | 70.46B | 64.11B | 63.86B |
| Operating income (EBIT) | 10.22B | 9.24B | 3.79B | 10.29B | 8.53B |
| Net income | 6.12B | 5.68B | 4.66B | 3.42B | 2.93B |
| Free cash flow | 1.10B | 2.83B | 2.40B | -7.64B | 5.23B |
| Total assets | 279.93B | 286.51B | 273.79B | 298.57B | 312.40B |
| Equity | 33.25B | 32.64B | 29.65B | 21.06B | 30.83B |
| Net debt | 1.93B | 205.00M | -3.86B | -2.87B | -1.98B |
PWP Leeway UG (haftungsbeschränkt)
